KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to $30.5 million.

  • Resmed's Net Cash Flow fell 7551.79% to $30.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $848.9 million, marking a year-over-year increase of 15369.85%. This contributed to the annual value of $945.3 million for FY2025, which is 765527.11% up from last year.
  • Per Resmed's latest filing, its Net Cash Flow stood at $30.5 million for Q4 2025, which was down 7551.79% from $174.5 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Net Cash Flow ranged from a high of $402.8 million in Q1 2025 and a low of -$81.4 million during Q4 2021
  • Moreover, its 5-year median value for Net Cash Flow was $18.8 million (2022), whereas its average is $57.8 million.
  • Per our database at Business Quant, Resmed's Net Cash Flow plummeted by 45416.31% in 2023 and then skyrocketed by 7479627.33% in 2025.
  • Quarter analysis of 5 years shows Resmed's Net Cash Flow stood at -$81.4 million in 2021, then soared by 143.15% to $35.1 million in 2022, then plummeted by 120.69% to -$7.3 million in 2023, then skyrocketed by 1811.28% to $124.4 million in 2024, then tumbled by 75.52% to $30.5 million in 2025.
  • Its Net Cash Flow was $30.5 million in Q4 2025, compared to $174.5 million in Q3 2025 and $241.2 million in Q2 2025.